Efficacy and safety of sacubitril/valsartan according to frailty in heart failure with preserved ejection fraction: a post hoc analysis of the PARAGON-HF trial
29 August 2022 (14:37 - 14:56)
Organised by:
About the speaker
Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
3 More presentations in this session
Doctor K. Bunting (Birmingham, GB)
Access the full session
The Event
ESC Congress 2022
29 August 2022
14:37 CET
You may be interested in
Congress Session
Congress Presentation
